Translate this page to:
Choose Language…
In JoVE (1)
Other Publications (4)
Articles by Yi Cheng in JoVE
JoVE Bioengineering
Bridging the Bio-Electronic Interface with Biofabrication
1Fischell Department of Bioengineering, University of Maryland, 2Institute for Bioscience and Biotechnology Research, University of Maryland, 3Department of Materials Science and Engineering, University of Maryland
This article describes a biofabrication approach: deposition of stimuli-responsive polysaccharides in the presence of biased electrodes to create biocompatible films which can be functionalized with cells or proteins. We demonstrate a bench-top strategy for the generation of the films as well as their basic uses for creating interactive biofunctionalized surfaces for lab-on-a-chip applications.
Other articles by Yi Cheng on PubMed
Learning to See Faces and Objects
Visual recognition of objects is an impressively difficult problem that biological systems solve effortlessly. We consider two aspects of this ability. First, is the recognition of all objects accomplished by either a single system or multiple, domain-specific systems? Behavioral, neuropsychological and neuroimaging data indicate that a single system is sufficient for the recognition of all objects at all levels. Second, how does such a system 'tune' itself to the constraints imposed by recognition at different levels of specificity? Evidence indicates that the task demands and learning that arise from different forms of feedback determine which computational routines are recruited automatically in object recognition.
Preparation and Characterization of Galactose-modified Liposomes by a Nonaqueous Enzymatic Reaction
In this study, NOH (NOH = N-octadecyl-4-[(D-galactopyranosyl)oxy]-2,3,5,6-tetrahydroxy hexanamide) was enzymatically synthesized as a targeting molecule and incorporated into liposomes to prepare a liposome surface modified with galactose. Glycyrrhetinic-acid-loaded liposome (GA-LP) and glycyrrhetinic-acid-loaded liposome surface modified with galactose (NOH-GA-LP) were prepared by the ethanol-injection method. NOH-GA-LP was characterized by morphology, particle size, zeta potential, encapsulation efficiency, release in vitro, and stability. The size of spherical particles was in the range of 179-211 nm. Spherical particles exhibit a positive electrical charge (38.7 mV) and possess high encapsulation efficiency (91.3%) and show sustained release (72% over 48 hours) in vitro. This novel approach for the liposome surface modified with galactose by enzymatic synthesis is expected to provide potential application as a drug carrier for active targeted delivery to hepatocytes.
Antiemetic Activity of Megestrol Acetate in Patients Receiving Chemotherapy
Several trials had independently noted that patients receiving megestrol acetate had less nausea and vomiting, but this antiemetic activity of megestrol acetate has not been reported separately in the literature. Our objective was to evaluate the antiemetic ability of megestrol acetate in patients receiving chemotherapy.
HPLC Assay and Pharmacokinetics and Tissue Distribution Study of Glycyrrhetinic Acid Liposomes Modified with Galactosylated Lipid
The aim of this study was to evaluate the pharmacokinetics and tissue distribution of the glycyrrhetinic acid (GA) liposome modified with galactosylated lipid (NOH-GA-LP), compared with GA conventional liposome (GA-LP) and GA solution in mice. The pharmacokinetics and biodistribution of liposomal and solution formulation of GA in mice were studied after intravenous administration. Plasma and tissues were treated using liquid-liquid extraction and determined using reversed-phase high-performance liquid chromatography. Results showed that the mean residence times of NOH-GA-LP (2.99-fold) and GA-LP (2.94-fold) were higher than that of the GA solution in plasma. NOH-GA-LP produced a drug concentration in the liver that was markedly higher than that in other tissues and was approximately 2.0- and 4.8-fold of that of GA-LP and GA solution, respectively. In conclusion, the NOH-GA-LP prepared in this study is a promising sustained-release and drug-targeting system for antitumor drugs.
